PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
19.93%
Some net income increase while ORCL is negative at -7.55%. John Neff would see a short-term edge over the struggling competitor.
-49.83%
Both reduce yoy D&A, with ORCL at -9.19%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
754.55%
Well above ORCL's 317.81% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
31.18%
Less working capital growth vs. ORCL's 99.42%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.18%
Lower 'other working capital' growth vs. ORCL's 99.42%. David Dodd would see fewer unexpected short-term demands on cash.
-51.60%
Negative yoy while ORCL is 14.01%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
15.60%
Operating cash flow growth below 50% of ORCL's 163.54%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
3.49%
Lower CapEx growth vs. ORCL's 16.74%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-69.37%
Negative yoy purchasing while ORCL stands at 55.59%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
60.81%
Proceeds from sales/maturities above 1.5x ORCL's 23.11%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
No Data
No Data available this quarter, please select a different quarter.
-137.86%
We reduce yoy invests while ORCL stands at 180.78%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
7.59%
Issuance growth of 7.59% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-379.43%
We cut yoy buybacks while ORCL is 82.50%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.